A recent study lead by researchers from Boston Children’s Hospital, the Department of Pediatrics at Harvard Medical School and several other institutions, reveals clinical trials for drugs approved as “treatment” for ADHD were not designed to assess adverse events or long-term safety and effectiveness.
Millions of children are prescribed ADHD drug “treatments” with essentially little or no understanding of the long-term safety or effectiveness of the drugs. According to the study, two thirds of the 6.4 million American children (including 10,000 toddlers) diagnosed with alleged ADHD are basically part of a fraudulent life-threatening drug experiment.
These ADHD “treatments,” Methylphenidate (Ritalin) and Amphetamine/Dextroamphetamine (Adderall) have long been known as “kiddie cocaine.” According to the Drug Enforcement Administration (DEA), ADHD drugs “produce discriminative stimulus effects similar to cocaine…; will substitute for each other and for cocaine in a number of paradigms…; and chronic high-dose administration of either drug in animals produces psychomotor stimulant toxicity including weight loss, stereotypic movements and death, and in clinical studies, they produce behavioral, psychological, subjective and reinforcing effects similar to cocaine.
Other known serious, even life-threatening effects of these ADHD “treatments” include: abnormal heart rate/rhythm, depression, hallucinations, homicidal ideation, insomnia, irritability, hostility, mania/ psychosis, seizures, stunted growth, stroke and sudden death.
This information has been known for years. There are 44 drug regulatory agency warnings issued by eight countries, warning that ADHD drugs/stimulants cause harmful side effects and the Food and Drug Administration’s (FDA) Adverse Event Reporting System (MedWatch) reveals more than 17,000 adverse reactions connected to ADHD drugs between 2004-2012.
Knowledge of this information makes it questionable that only now has a study been conducted on the safety and long-term effects of ADHD “treatments,” especially in light of the study’s findings. Researchers identified 32 clinical trials used to obtain approval of ADHD drugs and found the following:
1. Eleven drugs (55%) were approved with less than 100 participants.
2. The median length of time that the drug was tested prior to its approval was only four weeks.
3. 38% of the drugs were actually approved with participants studied less than four weeks.
4. The median number of participants studied per drug was 75.
The study of clinical trial data for all approved ADHD drugs is important. First, it is an admission that there is no medical or scientific proof that ADHD drugs are effective or safe. Second, there is abundant evidence to prove that these drugs are hazardous.
Most importantly, there is not now, nor has there ever been, any medical or scientific test to show that any child diagnosed “ADHD” is suffering from a medical condition requiring drugs to “treat” it.
Source: The Clinical Practitioner, Kelly Patricia O’Meara